Filter
883
Text search:
Pharmaceuticals
Featured
Recommendations
69
New Publications
264
Language
Document type
No document type
485
Guidelines
141
Studies & Reports
132
Manuals
52
Strategic & Response Plan
31
Training Material
11
Resource Platforms
11
Fact sheets
9
Situation Updates
6
Brochures
2
Online Courses
2
Infographics
1
Countries / Regions
Ethiopia
44
India
36
Kenya
31
Global
20
Uganda
19
Liberia
18
Nepal
17
Tanzania
16
Nigeria
15
Rwanda
15
Ghana
14
Bangladesh
14
Western and Central Europe
14
Philippines
13
South Africa
13
Namibia
13
Lesotho
11
Sierra Leone
10
Myanmar / Burma
10
Germany
9
Zambia
9
Malawi
9
Ukraine
9
Zimbabwe
8
Cambodia
8
Eswatini/ Swaziland
8
Congo, Democratic Republic of
6
Syria
6
Indonesia
6
Eastern Europe and Central Asia
6
Guinea
5
Botswana
5
Latin America and the Carribbean
5
Africa
5
Senegal
4
South Sudan
4
Benin
4
South–East Asia Region
4
Eastern Europe
4
Haiti
3
Thailand
3
Madagascar
3
Cameroon
2
Pakistan
2
Lebanon
2
Mozambique
2
Angola
2
Yemen
2
East and Southern Africa
2
Paraguay
2
Albania
2
Burkina Faso
1
Mali
1
USA
1
Iraq
1
Jordan
1
China
1
Ireland
1
Papua New Guinea
1
Sudan
1
Peru
1
Brazil
1
North Macedonia
1
Libya
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Bhutan
1
Palestine
1
Tajikistan
1
Russia
1
Moldova
1
Iran
1
Turkmenistan
1
Japan
1
Belgium
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
369
Clinical Guidelines
55
Public Health
43
Key Resources
33
Women & Child Health
23
Pharmacy & Technologies
23
Capacity Building
6
Protection & Security
1
Toolboxes
Pharmacy
141
AMR
62
COVID-19
43
Mental Health
39
TB
36
HIV
29
Rapid Response
27
Planetary Health
27
Ebola
18
Global Health Education
17
Caregiver
16
Conflict
13
NTDs
13
NCDs
12
Health Financing Toolbox
10
Refugee
8
Specific Hazards
8
Polio
6
Natural Hazards
6
Disability
3
Cholera
2
Social Ethics
2
South Sudan
1
These guidelines have been developed specifically to address ethical issues of conducting research in children.
This document contains: The systematic reviews and GRADE assessments used at the Index-TB Guideline Panel in July 2015; The Evidence to Decision tables that record the Panel’s assessment and recommendations from
this meeting
The Global Burden of Disease (GBD) study, a collaborative endeavour of the World
Health Organization (WHO), the World Bank and the Harvard School of Public Health,
drew the attention of the international health community to the burden of neurological
disorders and many other chronic conditions. T
...
This Practice Parameter reviews the evidence from research and clinical experience and highlights significant advances in the assessment and treatment of posttraumatic stress disorder since the previous Parameter was published in 1998. It highlights the importance of early identification of posttrau
...
20 February 2013
Update on 2004 Background Paper (Written by Saloni Tanna)
Priority Medicines for Europe and the World "A Public Health Approach to Innovation"
Areas for action include: increasing prioritisation and awareness of dementia; reducing the risk of dementia; diagnosis, treatment and care; support for dementia carers; strengthening information systems for dementia; and research and innovation.
This paper focuses on the Sustainable Development Goals related to poverty, economic growth, inequality, health, food production and the environment. It presents concrete examples of the underlying and complex aspects of antibiotic resistance and its impacts across different Sustainable Development
...
Identificando o risco de acidente vascular cerebral e melhorando desfechos em pacientes com fibrilação atrial na América Latina
DOI: 10.1590/1516-3180.2015.0222110716
Sao Paulo Med J. 2016; 134(6):534-42
Children's Health and the Environment WHO Training Package for the Health Sector World Health Organization
Neurological, Psychiatric, and Developmental Disorders: Meeting the Challenge in the Developing World
Institute of Medicine (US) Committee on Nervous System Disorders in Developing Countries.
Washington (DC): National Academies Press (US); 2001.
SCOPING QUESTION: In the management of prescription opioid dependence, does supervised dosing with a long-acting opioid medication result in less opioid use and related harms than non-prescription, detoxification or usual care?
Building laboratory testing capacity
Strategic Overview
